Literature DB >> 17674401

Stability of the dexamethasone suppression test in borderline personality disorder with and without comorbid PTSD: a one-year follow-up study.

Katja Wingenfeld1, Wolfgang Lange, Hella Wulff, Christina Berea, Thomas Beblo, Anamaria Silva Saavedra, Christoph Mensebach, Martin Driessen.   

Abstract

Alterations in hypothalamic-pituitary-adrenal axis feedback regulation have been repeatedly reported in patients with borderline personality disorder (BPD). Due to the cross-sectional design of these studies, little is known about the longitudinal course of HPA axis functioning. In a sample of 13 patients with BPD, the dexamethasone suppression test (DST) has been used in a one-year follow-up study. There were no changes of cortisol concentrations before or after dexamethasone intake between baseline and follow-up examination. Patients with comorbid posttraumatic stress disorder (PTSD) showed more pronounced cortisol suppression compared to those without PTSD. The DST seems to be a stable marker of alterations in HPA axis feedback regulation in BPD, which is also reflected by substantial correlations between percentage of cortisol suppression at baseline and follow-up examination. (c) 2007 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17674401     DOI: 10.1002/jclp.20396

Source DB:  PubMed          Journal:  J Clin Psychol        ISSN: 0021-9762


  4 in total

1.  Comorbidity of borderline personality disorder and posttraumatic stress disorder in the U.S. population.

Authors:  Jina Pagura; Murray B Stein; James M Bolton; Brian J Cox; Bridget Grant; Jitender Sareen
Journal:  J Psychiatr Res       Date:  2010-05-26       Impact factor: 4.791

Review 2.  Reliability of hypothalamic-pituitary-adrenal axis assessment methods for use in population-based studies.

Authors:  Sherita Hill Golden; Gary S Wand; Saurabh Malhotra; Ihab Kamel; Karen Horton
Journal:  Eur J Epidemiol       Date:  2011-04-30       Impact factor: 8.082

3.  Reproducibility and utility of an overnight 0.25 mg dexamethasone suppression test as a marker for glucocorticoid sensitivity in children with asthma.

Authors:  R H Willemsen; L van Leeuwen; T A S Voorend-van Bergen; Y B de Rijke; M W Pijnenburg; E L T van den Akker
Journal:  J Endocrinol Invest       Date:  2015-06-10       Impact factor: 4.256

Review 4.  Complex PTSD, affect dysregulation, and borderline personality disorder.

Authors:  Julian D Ford; Christine A Courtois
Journal:  Borderline Personal Disord Emot Dysregul       Date:  2014-07-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.